Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8(+) T Cells

Documenti analoghi

• Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy
  di: Dybul, Mark, et al.
  Pubblicazione: (2003)
• Evaluation of the Pathogenesis of Decreasing CD4(+) T Cell Counts in Human Immunodeficiency Virus Type 1–Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
  di: Nies-Kraske, Elizabeth, et al.
  Pubblicazione: (2009)
• Antiretroviral Treatment Interruptions Induced by the Kenyan Postelection Crisis Are Associated With Virological Failure
  di: Mann, Marita, et al.
  Pubblicazione: (2013)
• Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
  di: Dybul, Mark, et al.
  Pubblicazione: (2001)
• Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection
  di: Burton, CT, et al.
  Pubblicazione: (2005)